A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Eszopiclone drug





DrugBank Eszopiclone (DB00402)

11/18/2014
05:24 | Author: Evan Martin

Eszopiclone drug
DrugBank Eszopiclone (DB00402)

Eszopiclone, marketed by Sepracor under the brand-name Lunesta, is a Its main selling point is that it is approved by the U.S. Food and Drug.

Actions: positive allosteric modulator Kind: protein Organism: Human Pharmacological action: unknown Actions: substrate Kind: protein Organism: Human Pharmacological action: unknown Actions: substrate Kind: protein Organism: Human Pharmacological action: unknown Actions: substrate Kind: protein Organism: Human Pharmacological action: unknown Actions: substrate.

Following oral administration, eszopiclone is extensively metabolized by oxidation and demethylation.

Marioara MENDELOVICI, Anita LIBERMAN, Alex MAINFELD, Nina FINKELSTEIN, “ METHODS FOR PREPARING ESZOPICLONE CRYSTALLINE FORM A, SUBSTANTIALLY PURE ESZOPICLONE AND OPTICALLY ENRICHED ESZOPICLONE. ” U.S. Patent US, issued November 22, 2007. Kind: protein Organism: Human Pharmacological action: yes Actions: potentiator Kind: protein Organism: Human Pharmacological action: unknown Actions: agonist Kind: protein Organism: Human Pharmacological action: unknown Actions: agonist Kind: protein Organism: Human Pharmacological action: unknown Actions: agonist Kind: protein Organism: Human Pharmacological action: yes Actions: agonist Kind: protein group Organism: Human Pharmacological action: yes.

Its main selling point is that it is approved by the U.S. Food and Drug Administration for long-term use, unlike almost all other hypnotic sedatives, which are approved only for the relief of short-term (6-8 weeks) insomnia.

Eszopiclone, marketed by Sepracor under the brand-name Lunesta, is a nonbenzodiazepine hypnotic agent (viz., a sedative) used as a treatment for insomnia. Eszopiclone is the active stereoisomer of zopiclone, and belongs to the class of drugs known as cyclopyrrones.

Comments (0)



Lunesta New FDA Drug Approval CenterWatch

11/17/2014
03:12 | Author: Evan Martin

Eszopiclone drug
Lunesta New FDA Drug Approval CenterWatch

Lunesta (eszopiclone): For the treatment of insomnia and sleep maintenance. New approved drug details including side effects, uses and general information.

Final rule. Schedules of controlled substances: placement of Zopiclone into schedule IV. Fed Regist. 2005 Apr 4;70(63):16935-7. Drug Enforcement Administration, Department of Justice.

GABA slows down brain activity so that your mind and body can relax, enabling you to fall asleep and stay sleep. Lunesta is a nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class.

Comments (2)Read more

Eszopiclone (Lunesta) Drug Information - Indications, Dosage, Side

9/16/2014
01:32 | Author: Caitlin White

Eszopiclone drug
Eszopiclone (Lunesta) Drug Information - Indications, Dosage, Side

Latest prescription information about Eszopiclone. Learn how to pronounce the drug's name, its indications, dosage, how to take, when to take, when not to take.

Consult with our panel of doctors for any health related issue, seek their opinion on your medical reports, or get a second opinion from our medical experts. You can use, Skype or your mobile for convenient consultations.

Disclaimer - The contents of this site are for informational purposes only. Always seek the advice of a qualified physician or health provider for medical diagnosis and treatment.

Medindia only offers pharma products of the highest quality from leading manufacturers, and GMP certified products for both the export and domestic markets. India is the world capital for Pharmaceutical formulations, Herbal Medicines, and Nutraceuticals. Click here to submit your requirements.

Sell your health products or services on Medindia and reach millions of consumers every month! Partner with us to take your online business to the next level. Learn More.

RSS Facebook Twitter Google Plus Linked in Stumbleupon X View All View All View All View All View All View All View All View All View All View All View All View All.

Follow Us On.

Last Updated - October 20, 2014 - Designed & Managed by Medindia4u.com Pvt. Ltd. Hosted & Technical Support by FrontPoint Systems.

Comments (0)

Lunesta (Eszopiclone) - Drug Info, User Reviews, Side Effects

7/15/2014
01:44 | Author: Devin Garcia

Eszopiclone drug
Lunesta (Eszopiclone) - Drug Info, User Reviews, Side Effects

Media Articles Related to Lunesta (Eszopiclone). Start Sleep Drug Lunesta at Lower Dose for Safety, FDA Says Source: MedicineNet zolpidem Specialty.

Rx drug information, pharmaceutical research, clinical trials, news, and more.

Comments (0)

Wake-up call FDA lowers starting dose of sleep drug Lunesta, citing

5/14/2014
03:40 | Author: Caitlin White

Eszopiclone drug
Wake-up call FDA lowers starting dose of sleep drug Lunesta, citing

The current recommended starting dose of eszopiclone, the drug marketed as Lunesta, is 2 milligrams at bedtime for both men and women.

In some cases, contributors are sources or experts quoted in a story. Post contributors aren’t staff, but may write articles or columns. This commenter is a Washington Post contributor.

The Food and Drug Administration is worried that a sleeping pill you take tonight could make for a riskier drive to work tomorrow.

Thursday's news comes nearly a year and a half after the FDA said it would begin requiring manufacturers of popular sleep medications such as Ambien to scale back their recommended dosages for women, in light of data that detailed some people remain impaired well into the next morning after taking the drugs.

Fact Checkers contribute questions, information and facts to The Fact Checker.

Post Forum members consistently offer thought-provoking, timely comments on politics, national and international affairs.

That move affected the labeling of drugs that contain zolpidem, a widely used ingredient in sleep aids.

Comments (5)Read more